Provided by Tiger Fintech (Singapore) Pte. Ltd.

CMS

8.110
-0.293-3.49%
Volume:7.01M
Turnover:57.46M
Market Cap:19.78B
PE:11.43
High:8.410
Open:8.410
Low:8.080
Close:8.403
Loading ...

China Medical System - License, Collaboration and Distribution Agreement With Alpha Cognition

THOMSON REUTERS
·
08 Jan

Investors Continue Waiting On Sidelines For China Medical System Holdings Limited (HKG:867)

Simply Wall St.
·
07 Jan

Declining Stock and Decent Financials: Is The Market Wrong About China Medical System Holdings Limited (HKG:867)?

Simply Wall St.
·
17 Dec 2024

China Medical System Gets Commercialization Rights for Anti-Gout Drug

MT Newswires Live
·
03 Dec 2024

BRIEF-China Medical System Says Unit Entered Into Exclusive Commercialization Agreement

Reuters
·
02 Dec 2024

China Medical System - Deal for Commercialization of Class 1 Innovative Drug Abp-671 for Treatment of Gout & Hyperuricemia

THOMSON REUTERS
·
02 Dec 2024

China Medical System Holdings - Unit Entered Into Exclusive Commercialization Agreemen With Atom Therapeutics

THOMSON REUTERS
·
02 Dec 2024

China Medical System's CMS-D005 Approved for Clinical Trial by Chinese Regulator

MT Newswires Live
·
28 Nov 2024

BRIEF-China Medical System Gets Approval Of Drug Clinical Trials For Glucagon Receptor CMS-D005

Reuters
·
27 Nov 2024

China Medical System - Approval of Drug Clinical Trials for Glucagon Receptor CMS-D005 From Nmpa China

THOMSON REUTERS
·
27 Nov 2024

Investors in China Medical System Holdings (HKG:867) have unfortunately lost 31% over the last three years

Simply Wall St.
·
12 Nov 2024

China Medical System's Vitiligo Cream Gets NDA from Hong Kong Authorities, Shares Slide 3%

MT Newswires Live
·
06 Nov 2024

BRIEF-China Medical System Says New Drug Application Of Ruxolitinib Phosphate Cream Approved

Reuters
·
06 Nov 2024

China Medical System - New Drug Application of Ruxolitinib Phosphate Cream for Vitiligo Approved by Pharmacy & Poisons Board of Hong Kong

THOMSON REUTERS
·
05 Nov 2024